FDA Announces Leadership Changes for Drug and Biologics Regulators
The U.S. Food and Drug Administration is reshuffling its top drug and biologics regulators, following the resignation of former commissioner Marty Makary. Tracy Beth Høeg and Katherine Szarama are leaving their acting director roles at CDER and CBER respectively, to be replaced by Karim Mikhail and Michael Davis.
